Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muta

Showing results (861-870 of 889) with videos related to

Pageof 89
Sort By:
Nature Human Behaviour|January 28, 2026
Convergent transcriptomic and connectomic controllers of information integration and its anaesthetic breakdown across mammalian brainsAndrea I Luppi, Lynn Uhrig, Jordy Tasserie, et al.
Diabetes & Vascular Disease Research|December 14, 2023
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medicationKazuo Kobayashi, Masao Toyoda, Atsuhito Tone, et al.
Diabetes, Obesity & Metabolism|May 20, 2024
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease, Shunichiro Tsukamoto, Kazuo Kobayashi, et al.
Frontiers in Pharmacology|April 11, 2024
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP studyYoshimi Muta, Kazuo Kobayashi, Masao Toyoda, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 7, 2019
A risk prediction model in asymptomatic patients with severe aortic stenosis: CURRENT-AS risk scoreEri Minamino-Muta, Takao Kato, Takeshi Morimoto, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 30, 2018
Malignant disease as a comorbidity in patients with severe aortic stenosis: clinical presentation, outcomes, and managementEri Minamino-Muta, Takao Kato, Takeshi Morimoto, et al.
Nature Communications|December 13, 2023
Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesisYu Muta, Juan F Linares, Anxo Martinez-Ordoñez, et al.
Journal of the American College of Cardiology|October 20, 2015
Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic StenosisTomohiko Taniguchi, Takeshi Morimoto, Hiroki Shiomi, et al.
Cardiovascular Intervention and Therapeutics|March 15, 2020
Clinical outcome after surgical aortic valve replacement in low-risk Japanese patients with severe aortic stenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 31, 2017
Acute Heart Failure in Patients With Severe Aortic Stenosis　- Insights From the CURRENT AS RegistryKazuya Nagao, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Pageof 89

Showing results (861-870 of 889) with videos related to

Sort By:
Pageof 89
Nature Human Behaviour|January 28, 2026
Convergent transcriptomic and connectomic controllers of information integration and its anaesthetic breakdown across mammalian brainsAndrea I Luppi, Lynn Uhrig, Jordy Tasserie, et al.
Diabetes & Vascular Disease Research|December 14, 2023
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medicationKazuo Kobayashi, Masao Toyoda, Atsuhito Tone, et al.
Diabetes, Obesity & Metabolism|May 20, 2024
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease, Shunichiro Tsukamoto, Kazuo Kobayashi, et al.
Frontiers in Pharmacology|April 11, 2024
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP studyYoshimi Muta, Kazuo Kobayashi, Masao Toyoda, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 7, 2019
A risk prediction model in asymptomatic patients with severe aortic stenosis: CURRENT-AS risk scoreEri Minamino-Muta, Takao Kato, Takeshi Morimoto, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 30, 2018
Malignant disease as a comorbidity in patients with severe aortic stenosis: clinical presentation, outcomes, and managementEri Minamino-Muta, Takao Kato, Takeshi Morimoto, et al.
Nature Communications|December 13, 2023
Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesisYu Muta, Juan F Linares, Anxo Martinez-Ordoñez, et al.
Journal of the American College of Cardiology|October 20, 2015
Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic StenosisTomohiko Taniguchi, Takeshi Morimoto, Hiroki Shiomi, et al.
Cardiovascular Intervention and Therapeutics|March 15, 2020
Clinical outcome after surgical aortic valve replacement in low-risk Japanese patients with severe aortic stenosisYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 31, 2017
Acute Heart Failure in Patients With Severe Aortic Stenosis　- Insights From the CURRENT AS RegistryKazuya Nagao, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Pageof 89